SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Flowserve's Board of Directors elected Ajay Agrawal as a new member of the Board effective August 5, 2026, and appointed him to the Organization and Compensation Committee and Technology, Innovation and Risk Committee. The appointment increases the board from nine to ten directors and reflects the addition of a director with significant industrial and M&A experience.
View raw filing on EDGAR →Patrick T. Ellinor, M.D., Ph.D., a recognized leader in cardiovascular medicine and human genetics, was appointed as an independent director effective August 6, 2026, with an annual cash compensation of $40,000 and an option grant of 103,400 shares.
View raw filing on EDGAR →Robert Lisicki was appointed as interim executive vice president and interim chief commercial officer effective August 21, 2026, following L. Todd Edwards' resignation. Lisicki's compensation includes a base salary of $555,000, 50% target bonus, 145,000 option grant, and 55,000 RSUs, with severance arrangements.
View raw filing on EDGAR →The filing discloses both the departure of CFO Christopher McGinnis (effective August 5, 2026) and the appointment of Justin Fengler as Chief Financial Officer & Treasurer (effective August 6, 2026). While both events occur, the principal disclosed action centers on Fengler's appointment to the CFO role, which includes material compensatory arrangements ($600K RSU, $600K PSU, and $100K cash payment). The appointment of a new CFO is material to investors assessing financial leadership continuity and governance.
View raw filing on EDGAR →The Board approved an increase in board size from nine to ten members and appointed Stephen G. Pagliuca, former Co-Chair of Bain Capital and founder and CEO of PagsGroup, to the Board effective August 4, 2026.
View raw filing on EDGAR →Alex Goor was appointed as Chief Executive Officer and Class I director effective August 6, 2026, with employment terms including $530,000 base salary, 90% target bonus, and $6.75 million in equity awards (RSUs and PSUs). Concurrent with this appointment, Eric Remer resigned as CEO and Chairman but remains on the Board.
View raw filing on EDGAR →The filing discloses multiple board-level changes: Robert Lawless's retirement as Chair, Joseph Dominguez's election as Chair (in addition to his CEO role), Charles Harrington's appointment as Lead Independent Director with additional compensation ($50,000 annual retainer), and Roger Crandall's election as a new independent director. While Lawless's departure is mentioned, the primary focus and substance of the disclosure centers on the appointments and role transitions—particularly Dominguez becoming Chair and Crandall joining the board. The additional compensation arrangement for Harrington also supports the appointment classification. These are material governance changes affecting board leadership and composition.
View raw filing on EDGAR →John Hinshaw was appointed to the Board of Directors effective immediately, filling a vacancy on the recommendation of the nominating and corporate governance committee. Mr. Hinshaw was determined to be independent under NYSE rules and was appointed to two Board committees, with a prorated RSU grant of $176,250.
View raw filing on EDGAR →Skye Anderson was appointed as Executive Vice President and President of McDonald's USA, effective August 4, 2026, a senior executive role overseeing nearly 14,000 U.S. restaurants and the Company's largest market segment.
View raw filing on EDGAR →The Board appointed David J. Fallon and Michael C. Lenz as directors effective August 4, 2026, expanding the board from nine to eleven members. Both appointees are independent directors with significant executive experience (CFO roles at major public companies including Vertiv, FedEx, and Hexcel), and the company's CEO and Chairman explicitly noted their strategic value in capital allocation and large-scale operations. This is a clear executive appointment event material to investors assessing board composition and governance.
View raw filing on EDGAR →The notice discloses the appointment of Mr. Carlos Aníbal Fernandes de Almeida Júnior as Executive Vice President of Pulp Industrial Operations, Engineering and Energy, following the resignation of Mr. Aires Galhardo. While both a departure and appointment occur, the principal disclosed action is the appointment of a named executive to a senior officer role overseeing critical business operations (pulp, procurement, forestry, and Futuragene). This is material as it affects leadership of a core business segment.
View raw filing on EDGAR →Michael J. Petro was promoted to Executive Vice President, Chief Financial Officer on August 4, 2026. While the disclosure includes compensatory arrangements (base salary of $750,000, target incentive awards, and a $5,000,000 RSU grant), the principal disclosed action is Petro's appointment to a senior executive role. The appointment of a CFO is material to investors as it affects the company's financial leadership and governance structure.
View raw filing on EDGAR →The disclosure centers on the appointment of John R. Linker as Executive Vice President and Chief Financial Officer effective July 1, 2026, with his assumption of principal financial officer duties on July 31, 2026. While Thomas Oddo's appointment as Chief Accounting Officer is also mentioned, the principal event is Linker's appointment to a senior executive role. This is a material executive appointment requiring 8-K disclosure under Item 5.02(c).
View raw filing on EDGAR →The filing discloses the appointment of Heather Getz as Chief Executive Officer and Class II director of TELA Bio, effective August 3, 2026. While the section also covers the concurrent departure of Antony Koblish as CEO and director, the substantive focus and forward-looking impact center on Ms. Getz's appointment, her extensive healthcare/medical device executive background, and the detailed terms of her employment agreement including base salary ($650,000), bonus structure, severance provisions, and substantial equity grants (2.87 million shares in options and RSUs). This is a material C-suite leadership transition that would affect investor assessment of the company's strategic direction and governance.
View raw filing on EDGAR →Theresa E. Wagler was appointed President and Chief Executive Officer effective January 1, 2027, succeeding Mark D. Millett who is retiring from the CEO role to become Executive Chairman. The appointment also includes promotions of other senior officers (Poinsatte as CFO, Schneider, Alvarez, Anderson, and Graham in expanded roles), reflecting a comprehensive executive succession plan.
View raw filing on EDGAR →Adam Baxter was appointed as Chairman and President of StratCap Digital Infrastructure REIT, Inc., effective August 3, 2026, following the resignation of James A. Condon from these positions effective July 31, 2026.
View raw filing on EDGAR →The disclosure centers on the Board's appointment of Beth J. Kaplan as a director effective July 31, 2026, upon recommendation of the Nominating and Corporate Governance Committee. The filing confirms her independent status under Nasdaq and SEC rules and describes her standard non-employee director compensation. This is a clear executive appointment event.
View raw filing on EDGAR →The exhibit announces the appointment of Ms. Nan Shen as Chief Financial Officer of So-Young International Inc., effective August 3, 2026. She will oversee finance, human resources, legal and compliance functions. This is a material executive appointment of a C-suite officer responsible for critical financial and operational functions, and would affect a reasonable investor's assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →The Board elected Admiral James F. Caldwell Jr. to fill a newly authorized board position effective August 4, 2026, and appointed him to the Audit Committee and Governance Committee. This is a clear director appointment, which is material to investors as board composition affects governance and oversight. The disclosure centers on the appointment action rather than any departure or compensation arrangement.
View raw filing on EDGAR →Michelle Gilson was appointed to the Board of Directors effective August 1, 2026, and simultaneously appointed as chair of the Audit Committee. This is a clear executive appointment of a director and committee chair with relevant biotechnology and financial expertise. Board appointments and committee leadership changes are material governance events affecting the registrant's leadership structure.
View raw filing on EDGAR →John Pershing is appointed as Executive Vice President and Chief Human Resources Officer, effective October 2026, succeeding Matthew Pasch. Pershing brings extensive HR leadership experience from major retailers including Barnes & Noble, Canadian Tire, Ascena, and Best Buy.
View raw filing on EDGAR →David Barse was appointed as a Class II director of KinderCare's Board of Directors, effective August 3, 2026. The appointment includes an RSU award of $126,575 and reflects his extensive experience as a business leader, investor, and board member.
View raw filing on EDGAR →Thomas Surran was appointed as President and Chief Executive Officer and principal financial officer of Resideo Technologies effective August 3, 2026, following the completion of the ADI spin-off.
View raw filing on EDGAR →ADI appointed eight directors (including Christine Gorjanc, William Galvin, Cynthia Hostetler, Michael Kaufmann, Stephen O. LeClair, Nathan Sleeper, and Brian Walker) and six executive officers (Robert Aarnes as President and CEO, Michael Carlet as CFO, Jeannine Lane as General Counsel, Alicia Copeland as COO, Marco Cardazzi as Chief Merchandising Officer, and James Olender as CIO) effective upon consummation of the separation on August 3, 2026.
View raw filing on EDGAR →The exhibit announces the appointment of Dr. Zhifeng Li as Chief Technology Officer (CTO) of MAAS, effective August 4, 2026. The disclosure explicitly states this is "an important step in MAAS's strategic transformation into a full-stack AI industry platform" and describes his broad responsibilities for technology strategy, AI roadmap, platform architecture, and R&D management. This is a material executive appointment to a named officer role at a critical juncture in the company's AI transformation strategy.
View raw filing on EDGAR →The 6-K discloses the appointment of Howard Steinberg as Chief Legal Officer effective July 22, 2026, and Keren Maimon as Managing Director effective the same date. While the filing also mentions termination of an advisory services agreement with Pulsar Group, the principal disclosed actions are executive appointments. The CLO appointment is material given Steinberg's extensive background in legal, regulatory, and compliance roles at major financial institutions, which would be relevant to investor assessment of the company's governance and risk management.
View raw filing on EDGAR →Dr. Molly Carr was appointed as Chief Medical Officer of iBio effective July 31, 2026. The appointment includes compensatory arrangements (base salary of $470,000, 40% target bonus, and a 430,000-share inducement stock option award) and is material to the clinical-stage biotech company as it strengthens clinical leadership during a critical phase of pipeline advancement into the clinic.
View raw filing on EDGAR →Danka Radosavljevic was appointed Chief Operating Officer on July 31, 2026, a material executive position. While the disclosure also includes compensation details (base salary of $520,800 and 50% bonus target), the principal disclosed action is the appointment to the COO role. The appointment of a C-suite officer is material to investors assessing company leadership and governance.
View raw filing on EDGAR →Daniel C. Kleine was elected Chief Financial Officer effective July 30, 2026, a material appointment to a named executive officer role with associated compensation arrangements including a salary increase to $300,000 and a 20,000 RSU grant.
View raw filing on EDGAR →The filing discloses both the resignation of CEO Vincent J. Arnone (effective August 10, 2026) and the appointment of Ramesh Nuggihalli as the new Chief Executive Officer and President (effective August 10, 2026). While both events are disclosed, the principal action centers on the appointment of a new CEO following a months-long executive search process. The appointment is material to investors as it represents a significant leadership transition at the company. The compensatory arrangements disclosed in section (e) are ancillary to the appointment itself.
View raw filing on EDGAR →Charlie's Holdings appointed Henry Sicignano III as Chief Executive Officer, effective immediately on August 4, 2026. Sicignano, former CEO of 22nd Century Group, assumes leadership at a critical juncture for the company's regulatory and commercialization initiatives. Ryan Stump transitioned from COO to Board Member and strategic partnerships role.
View raw filing on EDGAR →The filing discloses the appointment of two new independent directors, Craig Hart and Nancy Novak, to MARA's board effective August 1, 2026, filling vacancies created by the resignations of Barbara Humpton and Georges Antoun. While both departures and appointments occur, the principal disclosed action centers on the appointment of the new directors with detailed biographical information and their specific roles (Hart on the Risk and Audit Committee). This is a material governance event affecting board composition at a public company.
View raw filing on EDGAR →The filing's principal disclosed action is the appointment of Darin Harper, the Company's Chief Financial Officer, as Chief Executive Officer effective August 3, 2026, following Tarun Lal's retirement. While the filing also discloses Lal's departure, Harper's appointment as CEO—a critical leadership role—is the dominant event. The filing extensively details Harper's background, compensation package ($650,000 base salary, 100% target bonus, 115% LTIP target, and a $6.5 million one-time equity grant), and employment agreement terms, reflecting the materiality of this executive succession to investors.
View raw filing on EDGAR →Daniel Lewis was appointed as Interim Chief Executive Officer effective immediately on August 3, 2026, following Founder Vishal Garg's mutual agreement to transition from the CEO role, representing a significant change in the company's leadership.
View raw filing on EDGAR →Michael E. Regan was elected as a Class of 2028 director on July 30, 2026, and appointed to the Audit Committee, Enterprise Risk Committee, and Finance Committee, bringing 35+ years of FDIC regulatory expertise. Diane Gigliotti was promoted to Senior Vice President and Chief Accounting Officer, assuming expanded responsibility for accounting strategy and financial reporting as a named executive officer.
View raw filing on EDGAR →VersaBank announced the appointment of Lawrence Chamberlain as Global Senior Vice President, Investor and Stakeholder Relations, effective immediately. This is a named executive appointment to a senior leadership role. The disclosure emphasizes his six-year consulting relationship with the Bank, his deep understanding of strategy, and his role at a critical inflection point for the company, making this a material executive appointment.
View raw filing on EDGAR →The filing discloses both a director departure (Ilene Eskenazi's resignation effective August 3, 2026) and a director appointment (Carrie Cassidy's appointment to the Board and Compensation Committee, also effective August 3, 2026). The principal disclosed action centers on the appointment of Cassidy, with detailed background on her qualifications, compensation terms ($50,000 annual retainer plus equity grant), and committee assignments. While a departure also occurred, the substantive focus and length of disclosure is on the new director appointment.
View raw filing on EDGAR →Kevin Kalicak was appointed as Chief Financial Officer and Treasurer of Portillo's, effective September 7, 2026, succeeding interim CFO Pamela Smith. The appointment includes a base salary of $500,000, a bonus target of 75%, a long-term incentive target of $750,000, and an inducement RSU grant of $825,000.
View raw filing on EDGAR →The filing discloses the appointment of Rhonda Davenport as Chief Human Resources Officer effective August 3, 2026. While the disclosure includes compensatory details (base salary of $375,000, sign-on bonus, STI and LTI targets, and severance plan eligibility), the principal action is the appointment of a named executive officer to a C-suite position. The compensation details are ancillary to the core event of her taking the CHRO role.
View raw filing on EDGAR →Cory S. Gunderson has been appointed President and Chief Executive Officer of Protiviti (Robert Half's subsidiary) effective January 1, 2027, and will become an executive officer of Robert Half. Joseph A. Tarantino is transitioning from CEO to Senior Managing Director as part of a long-term succession plan.
View raw filing on EDGAR →Anne Bramman has been appointed as Executive Vice President and Chief Financial Officer, effective August 19, 2026, with detailed compensation arrangements disclosed including base salary of $950,000, short-term incentive target of 150%, equity grants of $3,250,000, and sign-on awards totaling $1,750,000. This is a material C-suite appointment at a major retailer ($41.6B revenue) during an active CEO transition, making it highly material to investors.
View raw filing on EDGAR →Bernd Leukert was elected and appointed as a Class II director of Teradata's Board effective August 1, 2026, with a term expiring at the 2027 Annual Meeting. The filing explicitly states the Board approved his election and appointment to the Nominating and Governance Committee. This is a clear executive appointment event, material because board composition changes affect corporate governance and investor assessment of the company's leadership and strategic direction.
View raw filing on EDGAR →Carl S. Carande was appointed to the Board of Directors of United Community Banks Inc effective August 1, 2026, increasing the Board from 12 to 13 directors. Carande was also appointed to the Risk Committee and the subsidiary bank's board, bringing 40 years of financial services and consulting experience including 25 years in senior leadership roles at KPMG.
View raw filing on EDGAR →The disclosure announces the Reserve Bank of India's approval of the re-appointment of Mr. Ajay Kumar Gupta as Executive Director for a further two-year term (November 27, 2026 to November 26, 2028), following earlier Board approval and pending shareholder approval at the August 21, 2026 Annual General Meeting. This is a material executive appointment requiring regulatory and shareholder approval.
View raw filing on EDGAR →Jim Rozakis was appointed President and COO effective August 1, 2026, representing a significant promotion from his prior role as Executive Vice President and COO. While the disclosure also includes compensatory arrangements (base salary of $900,000, target cash incentive of $1,125,000, target long-term incentive of $4,000,000, and one-time equity awards), the principal disclosed action is the appointment to the President role in connection with the separation of President and CEO titles. This is material as it reflects a material change in executive leadership structure.
View raw filing on EDGAR →OGE Energy's Board elected Richard E. Muncrief as a new director effective August 1, 2026. The disclosure centers on the appointment of a highly qualified executive (retired President and CEO of Devon Energy) to the Board, with assignment to the Nominating, Corporate Governance and Stewardship Committee and the Audit Committee. This is a material governance event affecting board composition and oversight.
View raw filing on EDGAR →Mettler-Toledo appointed Natalia Shuman as a director effective August 3, 2026, with the Board determining she qualifies as independent under NYSE listing standards. The Board also resolved to increase its size from nine to ten directors in connection with this appointment. Shuman brings extensive executive experience including CEO roles at MISTRAS Group and Bureau Veritas North America.
View raw filing on EDGAR →The exhibit announces the appointment of Michael Halstead as Chief Executive Officer of Helus Pharma (Cybin Inc.), effective immediately. Halstead is a highly experienced pharmaceutical executive with 25 years of industry experience, most recently President of Intra-Cellular Therapies, where he led the company through commercialization and its $14.6 billion sale to Johnson & Johnson. This is a material executive appointment at a critical juncture as the company prepares for Phase 3 topline data readout in Q4 2026.
View raw filing on EDGAR →The filing discloses the appointment of Indira Agarwal as Senior Vice President, Chief Financial Officer, effective August 1, 2026, succeeding Damon Audia who was promoted to President of PTx & Corporate Strategy. While the filing also documents Agarwal's compensatory arrangement (base salary of $600,000, incentive compensation, and severance terms), the principal disclosed action centers on her appointment to the CFO role and Audia's promotion to a new strategic position. The appointment of a new CFO is material to investors as it affects the company's financial leadership and governance structure.
View raw filing on EDGAR →Michael G. O'Rourke and Leonard S. Caronia were appointed to Esquire Financial Holdings' board of directors effective upon completion of the Signature merger on August 1, 2026. O'Rourke also assumed the role of President of the Signature division.
View raw filing on EDGAR →